Form 4 for SLDB Solid Biosciences Inc.

Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-27 · accession 0000899243-23-003085 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-01-31	2023-01-27	SLDB	Morris Carl Ashley	CSO	S - Sale+OE	$7.49	-441	19.8K	-2%	-$3,303
D	2023-01-31	2023-01-27	SLDB	Morris Carl Ashley	CSO	M - OptEx	—	+1,233	20.2K	+7%	—
D	2023-01-31	2023-01-27	SLDB	Morris Carl Ashley	CSO	M - OptEx	$0.00	-1,233	3,700	-25%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-27	S	D	441	$7.49	19,760	D	—	—	(F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
2	Common	Common Stock	2023-01-27	M	A	1,233	—	20,201	D	—	—	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
3	Derivative	Restricted Stock Units	2023-01-27	M	D	1,233	$0.00	3,700	D	— · — to —	1,233 Common Stock	(F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) On January 27, 2022 (the "Grant Date"), the reporting person was granted 4,933 restricted stock units, vesting in four equal installments on the anniversary of the grant date.